View of CYP2C9*2 (rs1799853) POLYMORPHISM AS A PHARMACOGENETIC PREDICTOR OF METHOTREXATE HEPATOTOXICITY IN RHEUMATOID ARTHRITIS PATIENTS OF AN UZBEK POPULATION

Return to Article Details CYP2C9*2 (rs1799853) POLYMORPHISM AS A PHARMACOGENETIC PREDICTOR OF METHOTREXATE HEPATOTOXICITY IN RHEUMATOID ARTHRITIS PATIENTS OF AN UZBEK POPULATION Download Download PDF